Dr. Reddys Labaratories (ADRs) revenue breakdown overview

Dr. Reddys Labaratories (ADRs) revenue for the last year amounted to 3.10 B EUR, the most of which — 2.75 B EUR — came from its highest performing source at the moment, Global Generics, the year earlier bringing 2.45 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought Dr. Reddys Labaratories (ADRs) 1.52 B EUR, and the year before that — 1.22 B EUR.